Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-24 Purchase | 2022-03-25 4:15 pm | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 7,000 | $1.4 | $9,800 | 258,555 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-01 6:19 pm | N/A 2031-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-06-18 Exercise | 2021-06-21 4:15 pm | N/A 2021-06-30 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 24,720 | $0 | 251,555 (Direct) | View |
| 2021-06-18 Exercise | 2021-06-21 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 24,720 | $2.2 | 251,555 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-02 5:04 pm | N/A 2030-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 40,000 | $0 | 40,000 (Direct) | View |